Zepzelca 4 MG vials
Ended Awarded Last action
- Contract number
- SPE2DR26F1AM9
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $10,384
Award facts
- Contract value 100% obligated
- $10,384.04 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $10,384.04 firm fixed-price delivery order to AmerisourceBergen Drug Corp for the supply of Zepzelca 4 mg vials, a pharmaceutical product supporting federal medical procurement needs. The contract, awarded on January 22, 2026, with an ultimate completion date of February 12, 2026, represents a task order placed against AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical. This award was competitively awarded with no set-aside designation. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, serves as the prime contractor, with its parent company being Cencora, Inc., which also operates under the AmerisourceBergen brand name.
AmerisourceBergen holds a significant $999.999 billion IDC with DLA Troop Support Medical through December 2026, which serves as a comprehensive global pharmaceutical supply vehicle for military healthcare programs. This contract vehicle enables the company to deliver a broad range of pharmaceutical products, including specialty medications, brand-name and generic drugs, vaccines, and medical supplies to support the Defense Health Agency, U.S. Coast Guard, and other federal healthcare systems. The Zepzelca delivery order reflects the company's continued role as a critical vendor in the federal pharmaceutical supply chain, demonstrating its capability to fulfill specialized medical procurement requirements through open competition.
Quick answers
Who was awarded contract SPE2DR26F1AM9?
SPE2DR26F1AM9 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 22, 2026.
How much is contract SPE2DR26F1AM9 worth?
The government has obligated $10,384 on SPE2DR26F1AM9.
Is contract SPE2DR26F1AM9 an order under another contract?
Yes. SPE2DR26F1AM9 is a delivery order under SPE2DR25D1205, an indefinite delivery contract.
Was contract SPE2DR26F1AM9 competed?
The extent of competition for SPE2DR26F1AM9 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award